title: Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.
authors.forename: F
authors.initials: F
authors.lastname: Ayuk
authors.forename: A
authors.initials: A
authors.lastname: Shimoni
authors.forename: A
authors.initials: A
authors.lastname: Nagler
authors.forename: R
authors.initials: R
authors.lastname: Schwerdtfeger
authors.forename: M
authors.initials: M
authors.lastname: Kiehl
authors.forename: H G
authors.initials: HG
authors.lastname: Sayer
authors.forename: T
authors.initials: T
authors.lastname: Zabelina
authors.forename: A R
authors.initials: AR
authors.lastname: Zander
authors.forename: N
authors.initials: N
authors.lastname: Kröger
mesh_terms: D000328:Adult; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology* / Q000473:pathology; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D017710:Lymphocyte Transfusion / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000097:blood / Q000473:pathology / Q000628:therapy*; D014019:Tissue Donors; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous